For the treatment of Alzheimer's disease.

Used in patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.

For the treatment of scleroderma, cancer, and restenosis.

Investigated for use/treatment in anal dysplasia, cervical dysplasia/cancer, genital warts, HIV infection, infectious and parasitic disease (unspecified), pediatric indications, ...

Investigated for use/treatment in insomnia.

Investigated for use/treatment in cystic fibrosis, HIV infection, hepatitis (viral, B), and malaria.

For the treatment of rheumatoid arthritis and type 2 diabetes.

Investigated for use/treatment in hepatitis (viral, B), liver transplant surgery, and pediatric indications.

Investigated for use/treatment in diabetes mellitus type 1 and 2.

Investigated for use/treatment in head and neck cancer and lung cancer.

Investigated for use/treatment in pain (acute or chronic).

Investigated for use/treatment in hepatitis (viral, C), leukemia (myeloid), melanoma, and renal cell carcinoma.

Investigated for use/treatment in alzheimer's disease.

Investigated for use/treatment in ulcerative colitis.

Investigated for use/treatment in HIV infection.

Investigated for use/treatment in genital herpes.

Investigated for use/treatment in breast cancer, liver cancer, and prostate cancer.

Investigated for use/treatment in autoimmune diseases and inflammatory disorders (unspecified).